ARDX

Analyst Sentiment

Wall St. Consensus
Buy
16 analysts·Moderate coverage
75
Score
16 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
16100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$15.00
+103.7%
Consensus
$17.00
+130.8%
Bull
$19.00
+158.0%
12-Month Target Range16 analysts
$15.00$17.00$19.00
Current $7.37Consensus
Current Price
$7.37
Upside to Consensus
$9.63

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+35.22%
EPS
FY2028
Rev+32.67%
EPS+144.82%
FY2029
Rev+28.53%
EPS+60.70%

Earnings Surprises

Recent Analyst Actions

Mar 12, 2026Williams Trading
Leerink Partners Reiterates Outperform Rating on Ardelyx, Inc (ARDX) following conference
Target:$17.00
+200.4%from $5.66
Feb 20, 2026H.C. Wainwright
Ardelyx price target raised to $18 from $10 at H.C. Wainwright
Target:$18.00
+167.1%from $6.74
Jan 27, 2026Jefferies
Ardelyx price target raised to $15 from $8 at Jefferies
Target:$15.00
+92.3%from $7.80
Jan 9, 2026BTIG
Ardelyx price target raised to $17 from $14 at BTIG
Target:$17.00
+142.9%from $7.00
Jan 8, 2026Piper Sandler
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
Target:$16.00
+128.6%from $7.00
Jan 8, 2026Raymond James
Ardelyx price target raised to $19 from $16 at Raymond James
Target:$19.00
+171.6%from $7.00
Nov 4, 2025Piper Sandler
Ardelyx price target raised to $10 from $9 at Piper Sandler
Target:$10.00
+70.6%from $5.86
Aug 5, 2025Wedbush
Ardelyx price target raised to $14 from $13 at Wedbush
Target:$14.00
+172.9%from $5.13
Aug 5, 2025UBS
Ardelyx price target raised to $12 from $11 at Raymond James
Target:$12.00
+133.9%from $5.13
Mar 4, 2025BTIG
Ardelyx initiated with a Buy at BTIG
Target:$14.00
+158.8%from $5.41
Jan 2, 2025Jefferies
Ardelyx price target lowered to $8 from $11 at Jefferies
Target:$8.00
+56.3%from $5.12
Aug 5, 2024H.C. Wainwright
Ardelyx price target raised to $11 from $10 at H.C. Wainwright
Target:$11.00
+81.8%from $6.05
Jul 5, 2024H.C. Wainwright
Ardelyx, Inc (ARDX) PT Lowered to $10 at H.C. Wainwright
Target:$10.00
+89.0%from $5.29
May 24, 2024Raymond James
Ardelyx Chief Commercial Officer exit not positive, says Piper Sandler
Target:$15.00
+108.3%from $7.20
Dec 18, 2023Raymond James
Patient Demand Drives Ardelyx's Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst
Target:$12.00
+90.3%from $6.30
Dec 30, 2022Citigroup
Citigroup Maintains Buy on Ardelyx, Raises Price Target to $7
Target:$7.00
+145.6%from $2.85
Dec 29, 2022Wedbush
Ardelyx approval for tenapanor 'still far from a slam dunk,' says Wedbush
Target:$2.00
-14.3%from $2.33